Electrical storms in Brugada syndrome: Review of pharmacologic and ablative therapeutic options

Indian Pacing and Electrophysiology Journal

Volumn 5, Issue 1, 2005, Pages 25-34

  Maury, P ^a   Hocini, M ^b,c   Haissaguerre M ^b,c  

^a CHU RANGUEIL   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Ablation; Brugada syndrome; Electrical storm; Isoproterenol; Quinidine; Ventricular fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM TOSYLATE; CILOSTAZOL; DIHYDROQUINIDINE; DISOPYRAMIDE; DOBUTAMINE; ISOPRENALINE; LIDOCAINE; MAGNESIUM; MEXILETINE; PROCAINAMIDE; QUINIDINE; QUINIDINE ACID SULFATE; SOTALOL; TEDISAMIL;

BRUGADA SYNDROME; CATHETER ABLATION; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY; HEART ELECTROPHYSIOLOGY; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HUMAN; LETHALITY; OUTCOMES RESEARCH; QT PROLONGATION; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; REVIEW; ST SEGMENT ELEVATION; TREATMENT FAILURE;

EID: 23144454638     PISSN: 09726292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Brugada P, Brugada J. Right bundle branch block, persistant ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992; 20: 1391-1396.
2. Brugada J, Brugada R, Brugada P. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 2003; 14: 455-457.
3. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm. Sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000; 102: 742-747.
4. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators. J Am Coll Cardiol 1998; 33: 1909-1915.
5. Ayerza MR, De Zutter M, Goethals M, Wellens F, Geelen P, Brugada P. Heart transplantation as last resort against Brugada syndrome. J Cardiovasc Electrophysiol 2002; 13: 943-944
6. Maury P, Couderc P, Delay M, Boveda S, Brugada J. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace 2004; 6: 130-3.
7. Chalvidan T, Deharo JC, Dieuzaide P, Defaye P, Djiane P. Near fatal electrical storm in a patient equipped with an implantable cardioverter defibrillator for Brugada syndrome. Pacing Clin Electrophysiol 2000; 23: 410-412.
8. Dinckal MH, Davutoglu V, Akdemir I, Soydinc S, Kirilmaz A, Aksoy M. Incessant monomorphic ventricular tachycardia during febrile illness in a patient with Brugada syndrome: fatal electrical storm. Europace 2003; 5: 257-261.
9. Shimizu W, Kamakura S. Catecholamines in children with congenital long QT syndrome and Brugada syndrome. J Electrocardiol 2001; 34 Suppl: 173-175.
10. Suzuki H, Torigoe K, Numata O, Yazaki S. Infant case with a malignant form of Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1277-1280.
11. Tanaka H, Kinoshita O, Uchikawa S, et al. Successful Prevention of Recurrent Ventricular Fibrillation by Intravenous Isoproterenol in a Patient with Brugada Syndrome. Pacing Clin Electrophysiol 2001; 24: 1293-1294.
12. Mok NS, Chan NY, Chiu AC. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophyiol 2004; 27: 821-823
13. Nakamura M, Isobe M, Imamura H. Incessant ventricular fibrillation attacks in a patient with Brugada syndrome. Int J Cardiol 1998; 64: 205-206.
14. Pinar Bermudes E, Garcia-Alberola A, Martinez Sanchez J, Sanchez Munoz JS, Valdes Chavarri M. Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome. Pacing Clin Electrophysiol 2000; 23: 407-409.
15. Gonzalez Rebollo JM, Hernandez Madrid A, Garcia A, Garcia de Castro A, Mejias A, Moro C. Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome. Rev EspCardiol 2000; 53: 755-757.
16. Sastry BK, Narasimhan C, Soma Raju B. Brugada syndrome with monomorphic ventricular tachycardia in a one-year-old child. Indian Heart J 2001; 53: 203-205.
17. Alings M, Dekker L, Sadee A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol 2001; 24: 1420-1422.
18. Wilde AAM, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RNW, Kass RS, Nademanee K, Priori SG, Towbin JA. Proposed diagnostic criteria for the Brugada syndrome. Circulation 2002; 106: 2514-2519.
19. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y, Watanabe A, Nakamura K, Kusano KF, Emori T, Matsubara H, Hina K, Kita T, Ohe T. Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003; 42: 1624-1631.
20. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option ? Pacing Clin Electrophyiol 2002; 25: 1634-1640.
21. Alings M, Wilde A. « Brugada » syndrome: clinical data and suggested pathophysiological mechanisms. Circulation 1999; 99: 666-673.
22. Kasanuki H, Ohnishi S, Ohtura M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277-2285.
23. Nademanee K, Veerakul G, Mower M, et al. Defibrillator versus beta-blockers for Unexpected death in Thailand (DEBUT): a randomized clinical trial. Circulation 2003; 107: 2221-2226.
24. Antzelevitch C, Brugada P, Brugada J, Brugada R, Nedemanee K and Towbin J. Diagnosis. In Camm AJ ed: Clinical approaches to tachyarrhythmias (vol 10: The Brugada Syndrome). Futura Publishing Co., Inc., New York, 1999, p 43-50.
25. Antzelevitch C, Brugada P, Brugada J, Brugada R, Nademanee K and Towbin J. Pathogenesis and role of the autonomic nervous system. In Camm AJ ed: Clinical approaches to tachyarrhythmias (vol 10: The Brugada Syndrome). Futura Publishing Co., Inc., New York, 1999, p 33-38 and p 45-47.
26. Antzelevitch C. Ion and channels and ventricular arrhythmias: cellular and ionic mechanisms underlying the Brugada syndrome. Curr Opin Cardiol 1999; 14: 274-279.
27. Tsuchiya T, Ashikaga K, Honda T, Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome J Cardiovasc Electrophysiol 2002; 13: 698-701.
28. Yan GX, Antzelevitch C. Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-1666.
29. Miyazaki T, Mitamura AH, Miyoshi S, Soejima K, Aizawa Y and Ogawa S. Autonomic and antiarrhythmic modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070.
30. Proclemer A, Facchin D, Feruglio GA, Nucifora R. Recurrent ventricular fibrillation, right bundle branch block and persistent ST segment elevation in V1-V3: a new arrhythmia syndrome? A clinical case report. G Ital Cardiol 1993; 23: 1211-1218.
31. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004; 110: 1731-1737.
32. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 1999; 10: 1301-1312.
33. Garg A, Finneran W, Feld GK. Familial sudden cardiac death associated with a terminal QRS abnormality on surface 12-lead electrocardiogram in the index case. J Cardiovasc Electrophysiol 1998; 9: 642-647.
34. Hermida S, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004; 43: 1853-1860.
35. Chinushi M, Aizawa Y, Ogawa Y, Shiba M, Takahashi K. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrhythmias in a patient with Brugada syndrome. J Electrocardiol 1997; 30: 133-136.
36. Priori SG, Napolitano C, Schwartz PJ, Bloise R, crotti L, Ronchetti E. The elusive link between LQT3 and Brugada syndrome. The role of flecainide challenge. Circulation 2000; 102: 945-947.
37. Haïssaguerre M, Extramiana F, Hocini M, Cauchemez B, Jaïs P, Cabrera JA, Farre G, Leenhardt A, Sanders P, Scavée C, Hsu LF, Weerasooriya R, Shah DC, Frank R, Maury P, Delay M, Garrigue S, Clémenty J. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndrome. Circulation 2003, 108: 925-928.
38. Bansch D, Ouyang F, Antz M, Arentz T, Weber R, Val-Mejias JE, Ernst S, Kuck KH. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003; 108: 3011-3016.
39. Nakazawa K, Sakurai T, Takagi A, Kishi R, Osada K, nanke T, Miyake F, Matsumoto N, Kobayashi S. Autonomic imbalance as a property of symptomatic Brugada syndrome. Circ J 2003; 67: 511-514.
40. Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W, Aihara N, Kamakura S, Yamamoto F, Kobayashi J, Kosakai Y, Ohe T. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36: 1646-1653.
41. Boersma LVA, Jaarsma W, Jessurun ER, Van Hemel NHM, Wever EFD. Brugada syndrome: a case report of monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2001; 24: 112-115.
42. Shimada M, Miyazaki T, Miyoshi S, Soejima K, Hori S, Mitamura H, Ogawa S. Sustained monomorphic ventricular tachycardia on a patient with Brugada syndrome. Jpn Circ J 1996; 60: 364-370.
43. Vanpee D, Blommaert D, Gillet JB, De Roy L. A young man with recurrent syncopes, right bundle branch block and ST segment elevation. Am J Emerg Med 1999; 17: 601-603.
44. Martini B, Nava A, Ruzza L, Cannas S, Bauce B, Muriago A. La sindrome « morte improvvisa giovanile, blocco di branca destra e sopraslivellamento del stratto ST ». Giornale Italiano di Aritmologia e cardiostimulazione 1999; 2: 157-177.
45. Viskin S. Belhassen B. Clinical problem-solving: when you only live twice. New Engl J Med 1995; 332: 1221-1225.
46. Chinushi M, Washizuka T, Chinushi Y, Higuchi K, Toida T, Aizawa Y. Induction of ventricular fibrillation in Brugada syndrome by site-specific right ventricular premature depolarization. Pacing Clin Electrophysiol 2002; 25: 1649-1651.
47. Morita H, Fukushima-Kusano K, Nagase S, Takenaka-Morita S, Nishii N, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T. Site-specific arrhythmogenesis in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2003; 14: 373-379.
48. Haissaguerre M, Shah DC, Jais P, Shoda M, Kautzner J, Arentz T, Kalushe D, Kadish A, Griffith M, Gaita F, Yamane T, Garrigue S, Hocini M, Clementy J. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002; 359: 677-678.
49. Haissaguerre M, Shoda M, Jais P, Nogami A, Shah DC, Kautzner J, Arentz T, Kalushe D, Lamaison D, Griffith M, Cruz F, De Paola A, Gaita F, Hocini M, Garrigue S, Macle L, Weerasooriya R, Clementy J. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002; 106: 962-967.
50. Haissaguerre M, Weerasooriya R, Walczak F, Val Meijas J, Szumowski L, Hocini M, et al. Catheter ablation of polymorphic ventricular tachycardia or ventricular fibrillation in multiple substrates. In Santini M ed: Non pharmacological treatment of sudden death. Arianna Editrice, Bologna, 2003, p 237-253.